Mon, June 12, 2023
Fri, June 9, 2023
Thu, June 8, 2023
Wed, June 7, 2023
Tue, June 6, 2023
Mon, June 5, 2023

Edward Tenthoff Maintained (APTO) at Buy with Decreased Target to $37 on, Jun 7th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-37-on-jun-7th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Edward Tenthoff of Piper Sandler, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $45 to $37 on, Jun 7th, 2023.

Edward has made no other calls on APTO in the last 4 months.



There are 3 other peers that have a rating on APTO. Out of the 3 peers that are also analyzing APTO, 0 agree with Edward's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Edward


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Tuesday, May 9th, 2023
  • Matthew Biegler of "Oppenheimer" Reiterated at Buy and Held Target at $135 on, Tuesday, May 9th, 2023
  • Carey Macrury of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $120 on, Monday, March 27th, 2023